16 September 2014
UB researchers corroborate the neuroprotective effects of Sirtuin 1 activation on mice with Alzheimer's disease
A study coordinated by the University of Barcelona has described a mechanism that plays a key role in the evolution of Alzheimer’s disease (AD). The activation of the protein Sirtuin 1 in a murine model with familial AD has neuroprotective effects.
9 September 2014
Conversion of mild cognitive impairment to dementia among subjects with diabetes: a population-based five-year follow-up study
Researchers at Tianjin Medical University announced findings that suggest Type 2 diabetes mellitus with mild cognitive impairment accelerated progression to dementia by 2.74 years.
9 September 2014
Findings by University of Montana Professor Dr. Lilian Calderón-Garcidueñas, MA, MD, Ph.D., and her team of researchers reveal that children living in megacities are at increased risk for brain inflammation and neurodegenerative changes, including Alzheimer’s or Parkinson’s disease.
2 September 2014
In a large population-based study of randomly selected participants in Germany, researchers found that mild cognitive impairment occurred twice more often in individuals diagnosed with diabetes mellitus type 2.
25 August 2014
Marijuana compound may offer treatment for Alzheimer's disease, University of South Florida preclinical study indicates
Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer’s disease, a recent study from neuroscientists at the University of South Florida shows.
24 August 2014
Research published in JAD suggests healthy older adults are less capable of observing their own cognitive decline over an 18 month period than Cogstate’s computerized brief battery (CBB). The study also indicated that close family members were unable to perceive decline in the cognitive behavior of their partner in social settings.
17 August 2014
Rresearchers at the Blanchette Rockefeller Neurosciences Institute (BRNI) announced findings from a new study that offer significant promise for a new therapeutic and diagnostic approach to Alzheimer's disease (AD) that has remained so refractory to effective and early drug treatment.
12 August 2014
Decline in Daily Functioning Related to Decreased Brain Activity in Early Stages of Alzheimer's Disease
Decline in daily functioning associated with Alzheimer’s disease is related to alterations in activity in certain regions of the brain, according to a study published in the August 2014 issue of the Journal of Alzheimer’s Disease.
6 August 2014
In a long-term, large-scale population-based study of individuals aged 55 years or older in the general population researchers found that those diagnosed with mild cognitive impairment (MCI) had a four-fold increased risk of developing dementia or Alzheimer’s disease (AD) compared to cognitively healthy individuals.
6 August 2014
JAD Is Ranked as the Most Productive Journal and Mark Smith and George Perry Recognized as the Top Two Authors in the AD Research